Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 4:13:1609567.
doi: 10.3389/fcell.2025.1609567. eCollection 2025.

Assessment of synthetic post-therapeutic OCT images using the generative adversarial network in patients with macular edema secondary to retinal vein occlusion

Affiliations

Assessment of synthetic post-therapeutic OCT images using the generative adversarial network in patients with macular edema secondary to retinal vein occlusion

Shi Feng et al. Front Cell Dev Biol. .

Abstract

Aims: The aim of this study is to generate post-therapeutic optical coherence tomography (OCT) images based on pre-therapeutic OCT by using generative adversarial networks (GANs). The synthetic images enable us to predict the short-term therapeutic efficacy of intravitreal injection of anti-vascular endothelial growth factor (VEGF) in retinal vein occlusion (RVO) patients.

Methods: The study involved patients with RVO who received intravitreal anti-VEGF injection from 1 November 2018 to 30 November 2019. The OCT images taken before and shortly after treatment, with an interval of 4-8 weeks, were collected and randomly divided into the training set and test set at a ratio of approximately 3:1. The model is constructed based on the pix2pixHD algorithm, and synthetic OCT images are evaluated in terms of the picture quality, authenticity, the central retinal thickness (CRT), the maximal retinal thickness, the area of intraretinal cystoid fluid (IRC), and the area of subretinal fluid (SRF). Three supporting models, namely, the macular detection model, retinal stratification model, and lesion detection model, were constructed. Segmentation of macular location, retinal structure, and typical lesions were added to the input information. After verifying their accuracy, supporting models were used to detect the CRT, the maximal retinal thickness, IRC area, and SRF area of synthetic OCT images. The output predictive values are compared with real data according to the annotation on the real post-therapeutic OCT images.

Results: A total of 1,140 pairs of pre- and post-therapeutic OCT images obtained from 95 RVO eyes were included in the study, and 374 images were annotated. Of the synthetic images, 88% were considered to be qualified. The accuracy of discrimination of real versus synthetic OCT images was 0.56 and 0.44 for two retinal specialists, respectively. The accuracy to predict the treatment efficacy of CRT, the maximal retinal thickness, IRC area, and SRF area was 0.70, 0.70, 0.92, and 0.78, respectively.

Conclusion: Our study proves that the GAN is a reliable tool to predict the therapeutic efficacy of anti-VEGF injections in RVO patients. Evaluations conducted both qualitatively and quantitatively indicated that our model can generate high-quality post-therapeutic OCT images. Consequently, it has great potential in predicting the treatment efficacy and providing guidance to clinical decision-making.

Keywords: anti-vascular endothelial growth factor; generative adversarial networks; optical coherent tomography; retinal vein occlusion; therapeutic efficacy prediction.

PubMed Disclaimer

Conflict of interest statement

Authors JZ, YD and DD were employed by company Visionary Intelligence Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
A conceptual illustration of the pix2pixHD-based solution used in this study for generating post-therapeutic OCT images from pre-therapeutic OCT images.
FIGURE 2
FIGURE 2
(A–C) illustrated three cases with image quality issues. A1–C1 represent pre-therapeutic OCT images, A2–C2 represent synthetic post-therapeutic OCT images, and A3–C3 represent the real post-therapeutic OCT images. RPE discontinuity is shown in A2 (green line), retinal neuroepithelium discontinuity is shown in B2 (yellow arrow), and the entire retinal discontinuity is shown in C2 (red arrow).
FIGURE 3
FIGURE 3
(A–C) Three cases of pre-therapeutic, real post-therapeutic, and synthetic post-therapeutic OCT images. A1–C1 represent pre-therapeutic OCT images, A2–C2 represent synthetic post-therapeutic OCT images, and A3–C3 represent real post-therapeutic OCT images.
FIGURE 4
FIGURE 4
(A–D) Four cases of macular detection. A1–D1 represent the macular position annotated by retinal specialists (red circle). A2–D2 represent the macular position detected by the model (green circle). A3–D3 show the overlap between the annotated and detected positions.
FIGURE 5
FIGURE 5
(A–B) Two cases of retinal stratification. A1–B1 represent the original OCT images. A2–B2 represent the retinal stratification annotated by retinal specialists. A3–B3 represent retinal stratification detected by the model. A4–B4 show the overlap between the annotated and detected stratification. Black indicates class 0, green indicates class 1, and red indicates class 2.
FIGURE 6
FIGURE 6
(A–B) Two cases of lesion detection. A1–B1 represent the original OCT images. A2–B2 represent the lesions annotated by retinal specialists. A3–B3 represent the lesion detected by the model. A4–B4 show the overlap between the annotated and detected lesions. Black indicates class 0, green indicates class 1, and red indicates class 2.

Similar articles

Cited by

References

    1. Arrigo A., Crepaldi A., Vigano C., Aragona E., Lattanzio R., Scalia G., et al. (2021). Real-Life management of central and branch retinal vein occlusion: a seven-year follow-up study. Thromb. Haemost. 121 (10), 1361–1366. 10.1055/s-0041-1725197 - DOI - PubMed
    1. Baek J., He Y., Emamverdi M., Mahmoudi A., Nittala M. G., Corradetti G., et al. (2024). Prediction of long-term treatment outcomes for diabetic macular edema using a generative adversarial network. Transl. Vis. Sci. Technol. 13 (7), 4. 10.1167/tvst.13.7.4 - DOI - PMC - PubMed
    1. Costa J. V., Moura-Coelho N., Abreu A. C., Neves P., Ornelas M., Furtado M. J. (2021). Macular edema secondary to retinal vein occlusion in a real-life setting: a multicenter, nationwide, 3-year follow-up study. Graefes. Arch. Clin. Exp. Ophthalmol. 259 (2), 343–350. 10.1007/s00417-020-04932-0 - DOI - PubMed
    1. Hogg H. D. J., Talks S. J., Pearce M., Di Simplicio S. (2021). Real-world visual and neovascularisation outcomes from anti-VEGF in central retinal vein occlusion. Ophthalmic Epidemiol. 28 (1), 70–76. 10.1080/09286586.2020.1792937 - DOI - PubMed
    1. Horozoglu F., Sener H., Polat O. A., Temizyurek O., Evereklioglu C. (2023). Predictive impact of optical coherence tomography biomarkers in anti-vascular endothelial growth factor resistant macular edema treated with dexamethasone implant. Photodiagnosis Photodyn. Ther. 42, 103167. 10.1016/j.pdpdt.2022.103167 - DOI - PubMed

LinkOut - more resources